Testosterone Enanthate Cost in New York (2026)

What Does Testosterone Enanthate Actually Cost in New York?

The average cash price for a one-month supply of testosterone enanthate at New York retail pharmacies sits around $70 in 2026, based on 200 mg/mL vial pricing across major chains. That figure drops considerably with discount cards. It rises if you fill a branded version at full manufacturer list price, which runs approximately $120 per month.

Price variation across New York is real. A CVS in Manhattan may charge $15 to $20 more per vial than a Costco pharmacy in suburban Long Island. Walmart and Costco pharmacies in the state consistently post some of the lowest cash prices for generic testosterone enanthate, often between $35 and $55 for a 5 mL vial (1 to 000 mg total). That single vial, dosed at 100 to 200 mg per week, lasts four to ten weeks depending on your prescribed regimen.

The T-Trials, a coordinated set of seven placebo-controlled studies published in the New England Journal of Medicine (N=790 men aged 65 and older with low testosterone), confirmed that testosterone treatment improved sexual function, physical activity, and mood over 12 months 1. These findings underpin the clinical rationale for coverage by New York insurers and Medicaid alike, since demonstrated efficacy supports medical necessity arguments during prior authorization.

Generic testosterone enanthate is manufactured by multiple companies, including Hikma, Perrigo, and Sun Pharma. The generic market keeps prices competitive at retail, though the Schedule III classification means pharmacies cannot always substitute freely without prescriber authorization.

New York Medicaid Coverage for Testosterone Enanthate

New York Medicaid covers testosterone enanthate for diagnosed male hypogonadism, but prior authorization is required. The PA process verifies that the patient has two confirmed morning serum testosterone levels below 300 ng/dL, consistent symptoms, and no absolute contraindications such as breast or prostate cancer 2.

Approval typically takes three to five business days. If denied, your prescriber can submit a peer-to-peer review. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with "unequivocally low serum testosterone concentrations" combined with clinical symptoms, and New York Medicaid's PA criteria mirror this standard 2.

Once approved, Medicaid recipients pay $0 to $3 per fill depending on their specific plan. Managed Medicaid plans in New York (Fidelis Care, Healthfirst, Molina, Amerigroup, and others) each maintain their own formulary placement, but testosterone enanthate appears on nearly all of them as a preferred injectable androgen. If your plan requires a specific generic manufacturer, the pharmacy can usually order it within one to two business days.

For transgender men on New York Medicaid, coverage is also available. New York's Medicaid Transgender Health Care policy mandates coverage of hormone therapy as medically necessary treatment for gender dysphoria, and testosterone enanthate is the most commonly prescribed injectable formulation in this context.

How Insurance Plans in New York Handle Testosterone Enanthate

Most major commercial insurers operating in New York cover testosterone enanthate. Empire BlueCross BlueShield, UnitedHealthcare, Aetna, Cigna, and Oscar Health all include generic testosterone enanthate on their formularies, generally at Tier 2 (preferred generic) or Tier 3 (non-preferred generic) placement.

Copays range from $10 to $45 per month. Here is what shapes your out-of-pocket cost:

• Formulary tier. Tier 2 placement means lower copays ($10 to $20). Tier 3 pushes it to $30 to $45.
• Prior authorization. Nearly every plan requires PA for testosterone products, regardless of tier. Your prescriber must document low testosterone levels and symptoms.
• Quantity limits. Insurers commonly cap fills at one 5 mL vial per 30 days, which is adequate for most weekly dosing protocols.
• Step therapy. Some plans require trying topical testosterone (gels or patches) before approving injectables. This is less common in New York than in some other states, but Cigna and certain UnitedHealthcare plans do enforce it.

A 2020 analysis published in JAMA Internal Medicine found that prior authorization requirements for testosterone products delayed treatment initiation by a median of 11 days and led 16% of patients to abandon their prescriptions entirely 3. If you hit a step-therapy barrier, ask your prescriber to file a formulary exception citing injectable preference for adherence reasons or needle-phobia counseling documentation.

Employer-sponsored plans through large New York companies (finance, tech, healthcare sectors) tend to have more generous formulary placement. If you work for a self-insured employer, your HR benefits team can confirm whether testosterone is carved in or excluded.

Compounded Testosterone Enanthate in New York: Legality and Cost

Compounded testosterone enanthate is legal in New York through licensed 503A pharmacies. The cost averages $80 per month, though some compounding pharmacies charge $60 to $100 depending on concentration, vial size, and whether you add bacteriostatic water or syringes to your order.

New York's Board of Pharmacy maintains strict oversight of 503A compounding operations. Each pharmacy must hold a valid compounding license, follow USP 797 and USP 800 standards for sterile preparations, and compound only in response to individual patient prescriptions. The state does not permit 503B outsourcing facilities to ship compounded testosterone directly to patients without a prescriber relationship 4.

Why choose compounded over commercial? Three reasons appear most often:

1. Custom concentrations. Commercial vials come in 200 mg/mL. Compounded formulations can be prepared at 100, 150, or 250 mg/mL to match specific dose-volume preferences.
2. Alternative oils. Patients who react to the cottonseed or sesame oil in commercial products can request grapeseed or MCT oil bases from a compounding pharmacy.
3. Combined preparations. Some prescribers order testosterone enanthate compounded with anastrozole or HCG, though the clinical necessity of routine estrogen blockade during TRT remains debated. The Endocrine Society guideline advises against routine aromatase inhibitor use in most TRT patients 2.

Be aware that compounded testosterone products are not FDA-approved, meaning they have not undergone the same manufacturing validation as commercial generics. The FDA's 2023 safety communication on compounded hormones reiterated this distinction and warned consumers about potency variability 4.

Telehealth TRT Prescribing in New York

New York permits testosterone enanthate prescribing via telehealth. State law allows Schedule III controlled substances to be prescribed after a synchronous audio-video visit, provided the prescriber holds a valid New York medical license or is registered with an interstate compact.

Several telehealth TRT platforms operate in New York, including HealthRX, Hone Health, Peter MD, and Defy Medical. Pricing models vary. Some bundle the consultation, lab work, and medication into a single monthly fee ($150 to $250 per month). Others charge separately for the visit ($99 to $199) and let you fill at your own pharmacy.

When comparing telehealth options, check these specifics:

• Lab requirements. Reputable platforms require baseline bloodwork (total testosterone, free testosterone, LH, FSH, CBC, lipid panel, PSA for men over 40) before prescribing. The Endocrine Society recommends measuring testosterone between 7 and 10 AM on two separate mornings 2.
• Follow-up cadence. Standard of care calls for repeat labs at 3 months, 6 months, and then every 6 to 12 months. A platform that skips follow-up labs is a red flag.
• Pharmacy routing. Some platforms use their own compounding pharmacy. Others send prescriptions to retail chains where you can apply insurance or discount cards.

The Ryan Haight Online Pharmacy Consumer Protection Act requires at least one in-person or telemedicine evaluation before controlled substance prescribing. New York's telehealth parity laws, updated in 2023, treat synchronous video visits as equivalent to in-person encounters for this purpose 5.

Discount Programs and Savings Strategies for New York Patients

Multiple discount pathways can reduce your testosterone enanthate costs below the $70 average cash price. These work regardless of insurance status.

Pharmacy discount cards. GoodRx, RxSaver, and SingleCare aggregate negotiated rates from pharmacy benefit managers. In New York, GoodRx coupons bring testosterone enanthate 200 mg/mL (5 mL vial) to $28 to $48 at most chains. Costco pharmacy often posts the lowest discount-card price because it negotiates independently of major PBMs.

Manufacturer savings programs. Branded testosterone enanthate (Delatestryl) has limited manufacturer coupon availability in 2026, but generic manufacturers occasionally offer pharmacy rebate programs. Check the specific manufacturer's website or ask your pharmacist.

Patient assistance programs. For uninsured patients with household income below 200% of the federal poverty level ($31,200 for an individual in 2026), NeedyMeds and RxAssist maintain directories of testosterone assistance programs 6.

Mark Cuban's Cost Plus Drugs. This online pharmacy sells generic testosterone cypionate at near-wholesale pricing. While they do not currently stock testosterone enanthate specifically, testosterone cypionate is pharmacologically interchangeable (same ester class, same dosing interval, same efficacy profile), and Cost Plus ships to New York.

340B pharmacies. Federally Qualified Health Centers (FQHCs) in New York purchase medications through the 340B Drug Pricing Program at steep discounts and pass partial savings to qualifying patients. NYC Health + Hospitals operates multiple FQHC sites across all five boroughs. A 2022 study in Health Affairs found that 340B pharmacies offered testosterone products at 25% to 40% below average retail pricing 7.

Testosterone Enanthate vs. Cypionate: Cost Comparison in New York

Testosterone cypionate is the other commonly prescribed injectable ester. In New York, the two are priced similarly. Generic cypionate averages $65 to $75 per month at cash-pay retail, compared to $70 for enanthate. Insurance formularies treat them interchangeably in most cases.

The clinical differences are minimal. Both esters produce equivalent serum testosterone levels when dosed at the same milligram amount on the same schedule. A pharmacokinetic study published in the Journal of Clinical Endocrinology & Metabolism found no statistically significant difference in testosterone area-under-the-curve between enanthate and cypionate at 200 mg every two weeks 8.

So why does your prescriber choose one over the other? Mostly habit and oil vehicle. Enanthate typically uses sesame oil. Cypionate uses cottonseed oil. If you have a seed oil allergy, this distinction matters. Otherwise, the choice is clinically neutral, and you can request a switch if one is cheaper at your pharmacy.

The FDA-approved prescribing information for testosterone enanthate specifies intramuscular injection at doses of 50 to 400 mg every two to four weeks for male hypogonadism 9. Current clinical practice favors lower doses at weekly intervals (typically 100 to 200 mg per week) to maintain more stable serum levels and reduce peak-trough fluctuation.

What to Expect When Starting TRT in New York

Starting testosterone enanthate in New York follows a predictable sequence. Initial bloodwork costs $100 to $300 out of pocket if uninsured (Quest Diagnostics and Labcorp both operate extensively in the state). Your prescriber orders a comprehensive male hormone panel.

After confirming low testosterone on two separate morning draws, your prescriber submits the prescription and, if applicable, a prior authorization to your insurer. First fills are straightforward at retail pharmacies. Most patients self-inject at home after a brief training session.

The T-Trials demonstrated measurable improvements in sexual desire, erectile function, and walking distance within 3 to 6 months of treatment initiation 1. Monitoring labs at 3 months check hematocrit (to screen for polycythemia), PSA, and trough testosterone levels. The Endocrine Society recommends maintaining trough levels between 400 and 700 ng/dL and holding treatment if hematocrit exceeds 54% 2.

Dr. Shalender Bhasin, the principal investigator of the T-Trials and professor at Harvard Medical School, has stated: "Testosterone treatment in older men with low testosterone improved all aspects of sexual function, increased walking distance, and improved mood, but had no effect on vitality or cognitive function" 1.

A follow-up cardiovascular safety trial, TRAVERSE (N=5,246), published in the New England Journal of Medicine in 2023, found that testosterone replacement did not increase the incidence of major adverse cardiovascular events compared to placebo over a mean follow-up of 33 months 10. This result has eased prior FDA safety concerns and may simplify insurance approvals going forward. As Dr. Bhasin noted regarding TRAVERSE: "These findings should provide reassurance to clinicians and patients that testosterone therapy, when indicated, does not increase cardiovascular risk."